Quantcast

Latest Atopy Stories

2014-10-20 08:30:43

TARRYTOWN, N.Y. and PARIS, Oct. 20, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that the first patients have been dosed in a Phase 3 clinical study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, in adults with moderate-to-severe atopic dermatitis (AD) that is not adequately controlled with topical AD medications. LIBERTY AD CHRONOS, the first trial in the Phase 3 clinical...

2014-10-14 20:23:15

-New Yorkers with Severe Lung Diseases, Here is Your Rescue! SEOUL, South Korea, Oct. 14, 2014 /PRNewswire/ -- "About 123,000 patients with atopic dermatitis, rhinitis, and asthma and 32,000 patients with pulmonary emphysema, bronchiectasis, and pulmonary fibrosis have been cured." http://photos.prnewswire.com/prnvar/20141014/151916 There is a Korean medicine doctor who has cured hundred thousands of lives of patients with chronic allergic conditions, only with Korean medicine. He...

2014-10-13 12:27:31

DALLAS, October 13, 2014 /PRNewswire/ -- The EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023 is a 30 pages market research published in October 2014. Allergic conjunctivitis could be categorized as seasonal allergic conjunctivitis (SAC), which is the most common one, perennial allergic conjunctivitis (PAC), giant papillary conjunctivitis (GPC), vernal keratoconjunctivitis (VKC), and atopic keratoconjunctivitis (AKC) (Calonge, 1999). SAC and PAC...

2014-10-13 08:27:05

Aratana to Develop CRTH2 Antagonist for Atopic Dermatitis in Companion Animals KANSAS CITY, Kan. and OXFORD, United Kingdom, Oct. 13, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, and Atopix Therapeutics Ltd., a clinical stage company focused on innovative oral therapeutics for allergic diseases, today announced the completion...

2014-09-18 23:09:52

Margo Weaver, a Florida-based author, has released a new book aimed at helping children suffering from eczema to become more comfortable in their skin. APOPKA, Fla (PRWEB) September 18, 2014 According to the National Eczema Association, there are 30 million Americans who suffer from eczema, with many of them being children. In fact, they report that most people with the condition are first diagnosed as babies and children. The millions of children who have it often struggle with the...

2014-07-10 10:20:50

University of Rochester Medical Center URMC-led study offers hope for atopic dermatitis sufferers An investigational medication shows promise in treating the most common skin disorder, often referred to as eczema or atopic dermatitis, according to a study published July 9 in the New England Journal of Medicine. The findings could eventually bring significant relief for many who suffer intense itching and other troubling features of atopic dermatitis, according to the study's lead...

2014-07-09 16:28:51

Results from Earlier Clinical Trials Published Today in the New England Journal of Medicine TARRYTOWN, N.Y. and PARIS, July 9, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced positive results from a Phase 2b dose-ranging study of dupilumab, an investigational therapy, in adult patients with moderate-to-severe atopic dermatitis (AD), a serious, chronic form of eczema. All doses of dupilumab met the primary endpoint...

2014-07-09 08:28:37

EpiCeram(R) Controlled Release Skin Barrier Emulsion now offers dosing flexibility with 2 sizes SOUTH PLAINFIELD, N.J., July 9, 2014 /PRNewswire/ -- PuraCap(TM) Pharmaceutical today announced the newest addition to the EpiCeram(R) product line, the EpiCeram(R) 225g Airless Pump. The unique airless pump gives patients more EpiCeram(R) to treat any size area of atopic dermatitis. The special dispensing system allows for more control, delivering EpiCeram(R) consistently and precisely...

2014-07-08 23:15:50

Dignity Sciences Limited finds that a DGLA topical cream (DS107E) has an overall dose response improvement for Atopic Dermatitis in a Phase II clinical trial. Dublin, Ireland (PRWEB) July 08, 2014 Dignity Sciences Limited, a privately held biopharmaceutical company, today announced positive Phase II results for DS107E (DGLA cream), as a topical treatment for atopic dermatitis. This study was a randomized, placebo-controlled, double-blind, multi-centre Phase II study to investigate the...

2014-06-17 12:30:09

Partnership Represents LETI's Inaugural Launch in North America CHATHAM, N.J., June 17, 2014 /PRNewswire/ -- DermWORX Professional Skincare and LETI Laboratories announce plans to launch a series of top European dermatological products in the United States. This includes LETI's leading dermatology line for atopic skin, AT4, which DermWORX will market to U.S. healthcare professionals and their patients beginning in Q3, 2014. LETI Laboratories, a strategic founding partner for...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.